儿童原发性EB病毒感染相关转氨酶升高的危险因素与规律
回顾性分析399例原发性EB病毒感染患儿,51.9%发生转氨酶异常,年龄与转氨酶升高相关(OR=1.13、1.10,均P<0.05)。转氨酶升高以轻度为主,约半数在3周内恢复正常,8周内大部分恢复正常。
要点
- 年龄是儿童原发性EB病毒感染伴转氨酶升高的相关危险因素。
- 转氨酶升高以轻度为主,ALT轻度占74.5%,AST轻度占83.8%。
- 约半数转氨酶升高在3周内恢复,8周内大部分恢复。
核心结论
- 年龄是儿童原发性EB病毒感染伴随转氨酶升高的相关危险因素。
- 升高的转氨酶经3周后约半数恢复正常,8周后大部分恢复正常。
研究设计与样本
- 回顾性分析2016年9月至2017年10月复旦大学附属儿科医院门诊就诊的399例原发性EB病毒感染患儿的临床信息。
- 采用多元Logistic回归分析ALT或AST升高与年龄、性别、热程及血浆EBV-DNA病毒载量的相关性。
- 计算转氨酶异常患儿各时间段累计恢复正常率。
主要发现
- 399例患儿中男219例、女180例,年龄(4.2±2.7)岁,51.9%(207/399)发生转氨酶异常。
- ALT轻度(40~160 U/L)、中度(>160~400 U/L)、重度(>400 U/L)升高分别占74.5%(149/200)、21.0%(42/200)、4.5%(9/200)。
- AST轻度(40~160 U/L)、中度(>160~400 U/L)、重度(>400 U/L)升高分别占83.8%(155/185)、11.9%(22/185)、4.3%(8/185)。
- 年龄与发生转氨酶升高相关(OR=1.13、1.10,均P<0.05)。
- 113例ALT异常和104例AST异常病例有复查,ALT完全恢复正常(24±13)d,AST为(25±18)d。
关键数值与推荐
- ALT累计恢复正常率:<1周2.7%(3/113)、1~<4周54.0%(61/113)、4~<8周79.6%(90/113)、≥8周81.4%(92/113)。
- AST累计恢复正常率:<1周1.9%(2/104)、1~<4周48.1%(50/104)、4~<8周71.2%(74/104)、≥8周74.0%(77/104)。
临床怎么用
- 对原发性EB病毒感染患儿应关注年龄因素,年龄较大者可能更易出现转氨酶升高。
- 转氨酶升高以轻度为主,多数在3周内恢复,8周内大部分恢复,可据此安排复查随访。
局限性
- 本研究为单中心回顾性分析,仅纳入门诊患儿。
- 部分转氨酶异常患儿未进行复查,累计恢复率基于有复查资料的病例计算。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the risk factors and regularity of pediatric primary Epstein-Barr virus (EBV) infection accompanied with elevated transaminase. Methods: Clinical data of 399 children diagnosed as primary EBV infection in the outpatient department, Children's Hospital of Fudan University from September 2016 to October 2017 were analyzed retrospectively. Logistic regression analysis was performed to determine the potential correlations between elevated alanine transaminase (ALT) or aspartate transaminase (AST) and age, gender, course of fever and plasma EBV-DNA load. The cumulative rates of elevated transaminase recovery to nomal at different times were caculated. Results: Among 399 children diagnosed with primary EBV infection, there were 219 males and 180 females. The age was (4.2±2.7) years. Among all cases, 51.9% (207/399) had elevated transaminase. In patients who had elevated ALT, 74.5% (149/200), 21.0% (42/200) and 4.5% (9/200) had mild (40-160 U/L), moderate (160-400 U/L) and severe (>400 U/L) elevation of ALT, respectively. In patients who had elevated AST, 83.8% (155/185), 11.9% (22/185) and 4.3% (8/185) had mild (40-160 U/L), moderate (160-400 U/L) and severe (>400 U/L) elevation of AST, respectively. Only age was correlated with the occurrence of elevated transaminase (OR=1.13, 1.10, both P<0.05). A total of 167 repeated tests were ordered in patients with elevated ALT and/or AST, including 113 cases with elevated ALT and 104 cases with elevated AST. The time of ALT and AST returned to normal were (24±13) days and (25±18) days respectively. The cumulative rates for ALT returned to normal within 1, 1-<4, 4-<8 weeks and more than 8 weeks were 2.7% (3/113), 54.0% (61/113), 79.6% (90/113) and 81.4% (92/113) respectively, and were 1.9% (2/104), 48.1% (50/104), 71.2% (74/104) and 74.0% (77/104) for AST. Conclusions: Age is a risk factor for transaminase elevation associated with primary EBV infection in children. The transaminases returned to normal within 3 weeks in half of the cases, and within 8 weeks in most cases. 目的: 探讨影响儿童原发性EB病毒感染伴随转氨酶升高的相关因素及其变化规律。 方法: 回顾性分析2016年9月至2017年10月复旦大学附属儿科医院门诊就诊的399例原发性EB病毒感染患儿的临床信息。对丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)是否升高与患儿年龄、性别、热程及血浆EB病毒-DNA病毒载量的可能相关性进行多元Logistic 回归分析,计算转氨酶异常患儿各时间段累计恢复正常率。 结果: 399例原发性EB病毒感染患儿中男219例、女180例,年龄(4.2±2.7)岁。51.9%(207例)发生转氨酶异常;轻(40~160 U/L)、中(>160~400 U/L)和重度升高(>400 U/L)ALT分别有74.5%(149/200)、21.0%(42/200)和4.5%(9/200),AST分别为83.8%(155/185)、11.9%(22/185)和4.3%(8/185)。年龄与发生转氨酶升高相关(OR=1.13、1.10,均P<0.05)。113例ALT异常和104例AST异常病例有复查转氨酶,共复查167次;ALT完全恢复正常(24±13)d,AST为(25±18)d。<1、1~<4 、4~<8和≥8周 ALT累计恢复正常率为2.7%(3/113)、54.0%(61/113) 、79.6%(90/113)和81.4%(92/113),AST为1.9%(2/104)、48.1%(50/104)、71.2%(74/104)和74.0%(77/104)。 结论: 年龄是儿童原发性EB病毒感染伴随转氨酶升高的相关危险因素;升高的转氨酶经3周后约半数恢复正常,8周后大部分恢复正常。.
引用
- Zhang YH, Li F, Shi P, et al. [Risk factors and regularity of transaminase elevation associated with primary Epstein-Barr virus infection in children]. Zhonghua Er Ke Za Zhi. 2021. PMID: 34333915. doi:10.3760/cma.j.cn112140-20210401-00282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。